GemSarc: A Novel Predictive Gene Signature for Gemcitabine Efficacy in Advanced Bone and Soft Tissue Sarcomas
There are no validated predictive biomarkers for chemotherapy response in advanced soft-tissue sarcoma. We sought to develop and validate an RNA-based gene signature predictive of gemcitabine response. Patients treated with gemcitabine-based chemotherapy were identified from The Ohio State University (OSU)...